Panplex 2-Phase
En vente sur le marché américain (selon le DSLD)
Integrative Therapeutics, food supplement from the US market
Panplex 2-Phase (Integrative Therapeutics), a food supplement au code-barres 871791001770, is described by its US market label, recorded on 19 May 2022. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 19 May 2022. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Integrative Therapeutics
- Barcode
- 871791001770
- Form
- Tablet
- One serving
- 2 tablets
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Dicalcium Phosphate, Lactose Monohydrate, Hydroxypropyl Cellulose, Stearic Acid, Calcium Carbonate, Cellulose, Magnesium Stearate, Silica
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Phase I | Blend | 740 mg |
| Betaine HCl | Other substance | 320 mg |
| Pepsin Concentrate | Enzyme | 220 mg |
| L-Glutamic Acid Hydrochloride | Amino acid | 200 mg |
| Phase II | Blend | 298 mg |
| Pancreatin USP | Blend | 168 mg |
| Amylase | Enzyme | not stated |
| Protease | Enzyme | not stated |
| Lipase | Enzyme | not stated |
| Ox Bile | Ingredient of animal origin | 130 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Panplex 2-Phase
Entered into DSLD on 25 February 2019. Retirée du marché américain le 12 October 2021 (selon le DSLD).- Same quantity, different name: L-Glutamic Acid in this version; L-Glutamic Acid Hydrochloride on the displayed label (200 mg)
- Different unit, without conversion : Phase I: quantity not stated in this version; 740 mg on the displayed label
- Different unit, without conversion : Phase II: quantity not stated in this version; 298 mg on the displayed label
Official label: Panplex 2-Phase
Entered into DSLD on 21 October 2017. Retirée du marché américain le 21 June 2018 (selon le DSLD).- Same quantity, different name: L-Glutamic Acid in this version; L-Glutamic Acid Hydrochloride on the displayed label (200 mg)
- Different unit, without conversion : Phase I: quantity not stated in this version; 740 mg on the displayed label
- Different unit, without conversion : Phase II: quantity not stated in this version; 298 mg on the displayed label
Official label: Panplex 2-Phase
Entered into DSLD on 22 October 2016. Retirée du marché américain le 21 June 2017 (selon le DSLD).- Same quantity, different name: L-Glutamic Acid in this version; L-Glutamic Acid Hydrochloride on the displayed label (200 mg)
- Same quantity, different name: Ox Bile extract in this version; Ox Bile on the displayed label (130 mg)
- Different unit, without conversion : PHASE I: quantity not stated in this version; 740 mg on the displayed label
- Different unit, without conversion : PHASE II: quantity not stated in this version; 298 mg on the displayed label
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Integrative Therapeutics